This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Ciprofloxacin

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Activity:

  • Gram negative and Gram positive infections including shigella, salmonella, campylobacter, neisseria, pseudomonas and some mycobacteria. It has only moderate activity against Gram positive bacteria such as Strep influenzae and faecalis. It is active against some mycobacteria and chlamydia. The majority of anaerobic infections are not susceptible to ciprofloxacin

Cautions;

  • drug interactions
    • theophylline levels increase with concurrent ciprofloxacin
    • warfarin and other anticoagulants:
      • bleeding time increases
      • monitor creatinine with cyclosporin
  • epilepsy and history of CNS disorders
  • patients with AIDS - anaphylaxis has been reported
  • alkalinity of urine
  • inadequate fluid intake
  • renal impairment
  • Pregnancy and breast feeding
  • G6PD deficiency
  • children and growing adolescents - ciprofloxacin is contra-indicated except where the benefits of treatment outweigh the risks

Routes of administration:

  • oral
  • tablets
  • i.v. infusion
  • eye drops

The summary of product characteristics should be consulted before prescribing this drug.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.